Emergence of dual-resistance HBV mutations to adefovir-dipivoxil and lamivudine in a hepatitis B patient with combination therapy for adefovir resistance

被引:0
|
作者
Kwon, S. Y.
Lee, C. H.
Choi, W. H.
Yeon, J. E.
Byun, K. S.
机构
[1] Konkuk Univ Hosp, Dept Internal Med, Seoul, South Korea
[2] Korea Univ, Guro Hosp, Dept Internal Med, Seoul, South Korea
关键词
D O I
10.1016/S0168-8278(06)80741-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
740
引用
收藏
页码:S273 / S274
页数:2
相关论文
共 50 条
  • [31] COMPARISON ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY WITH ADEFOVIR MONOTHERAPY IN LAMIVUDINE RESISTANT CHRONIC HEPATITIS B
    Park, Woo Young
    Hwang, Jaeseok
    Jang, Byoung Kuk
    Shin, Jung Woo
    Park, Neung Hwa
    Lee, Byung Seok
    Lee, Joon Hyoek
    Bae, Si Hyun
    Tak, Won Young
    Lee, June Sung
    Lee, Chun Kyon
    Baik, Soon Koo
    Lee, Tae Hee
    Lee, Youn Jae
    HEPATOLOGY, 2009, 50 (04) : 531A - 532A
  • [32] Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: Immediate switch to adefovir dipivoxil appears to be indicated
    Wiegand, J
    Tischendorf, JJW
    Nashan, B
    Klempnauer, J
    Flemming, P
    Niemann, P
    Rohde, P
    Manns, MP
    Trautwein, C
    Tillmann, HL
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2004, 42 (01): : 15 - 18
  • [33] Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance
    Chen, Chien-Hung
    Lee, Chuan-Mo
    Tung, Wei-Chih
    Wang, Jing-Houng
    Hung, Chao-Hung
    Hu, Tsung-Hui
    Wang, Jyh-Chwan
    Lu, Sheng-Nan
    Changchien, Chi-Sin
    JOURNAL OF HEPATOLOGY, 2010, 52 (04) : 478 - 485
  • [34] Combination of telbivudine and adefovir dipivoxil therapy in chronic hepatitis B patients with poor response to adefovir dipivoxil monotherapy
    Chen, E. -Q.
    Zhou, T. -Y.
    Tang, H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S18 - S18
  • [35] Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance
    Yang, Hyo-Joon
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (03) : 424 - 430
  • [36] Resistance profile of adefovir dipivoxil (ADV) in immunocompetent and immunocompromised chronic hepatitis B patients after 48 weeks of adefovir dipivoxil therapy
    Westland, CE
    Yang, H
    Delaney, WE
    Thibault, V
    Benhamou, Y
    Gibbs, CS
    Miller, MD
    Wulfsohn, M
    Sullivan, M
    Fry, J
    Brosgart, CL
    Xiong, S
    JOURNAL OF HEPATOLOGY, 2003, 38 : 182 - 182
  • [37] Complex dynamics of hepatitis B virus resistance to adefovir dipivoxil
    Pallier, C.
    Rodriguez, C.
    Brillet, R.
    Hezode, C.
    Pawlotsky, J-M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S26 - S26
  • [38] Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
    Kim, Jeong Han
    Ko, Soon Young
    Choe, Won Hyeok
    Kwon, So Young
    Lee, Chang Hong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (03) : 273 - 279
  • [39] Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil
    Lu, Jia-Jie
    Liu, Kai
    Ma, Yuan-Ji
    Wang, Juan
    Chen, En-Qiang
    Tang, Hong
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 40 - 45
  • [40] HBV quasispecies selected during lamivudine treatment may contribute to adefovir dipivoxil resistance
    Moriconi, F.
    Flichman, D.
    Ciccorossi, P.
    Coco, B.
    Sacco, R.
    Oliveri, F.
    Colombatto, P.
    Bonino, F.
    Brunetto, M. R.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S188 - S188